Source: Southern Glazer’s.
  • Tilray (TLRY) has signed a distribution agreement with Southern Glazer’s Wine & Spirits
  • The distribution agreement will provide Tilray with direct access to Southern Glazer’s distribution network reaching consumers from local bars and restaurants to independent and national grocery chains, and convenience stores
  • Southern Glazer’s will be the exclusive distribution partner for the Tilray Wellness CBD beverage portfolio across 13 states with additional opportunities to scale nationwide
  • Tilray can develop a U.S. CBD beverage portfolio within familiar retail channels
  • Tilray Stock (TSX:TLRY) is up 0.73 per cent, trading at C$3.9285 per share at 12:00 pm ET

Tilray Brands’ (TLRY) wellness cannabis division has signed a distribution agreement with Southern Glazer’s Wine & Spirits.

Through Fresh Hemp Foods, Ltd., the distribution agreement will provide Tilray with direct access to Southern Glazer’s distribution network reaching consumers from local bars and restaurants to independent and national grocery chains and convenience stores.

Southern Glazer’s will be the exclusive distribution partner for the Tilray Wellness CBD beverage portfolio across 13 states, with additional opportunities to scale nationwide. Tilray can develop a U.S. CBD beverage portfolio within familiar retail channels via this partnership.

Glazer’s Wine & Spirits is the preeminent distributor of wine and spirits.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. The company is one of the biggest suppliers of medicinal cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.


More From The Market Online

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.